Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: Covid-19

August 31, 2026 Drug delivery / Pharma applications

Enhancing Remdesivir Delivery: PJL Micelles vs SBECD Formulations

Remdesivir (REM), a nucleoside analogue that has been approved for SARS-CoV-2 treatment, is poorly soluble in water and is currently

Continue reading

January 28, 2026 Pharma applications

Drug Repurposing as an Effective Drug Discovery Strategy

Drug repurposing, or repositioning, has emerged as a pivotal strategy in pharmaceutical research, offering a promising approach to uncover new

Continue reading

January 9, 2026 CD as API / Pharma applications

Hydroxypropyl-Beta-Cyclodextrin (HPBCD) inhibits SARS-CoV-2 replication by modulating intracellular lipid dynamics

A multi-year scientific collaboration between Brasilian and American scientists from Federal University at Rio de Janeiro, Brazil, Laboratory of Immunoregulation,

Continue reading

May 1, 2025 CD as API / Pharma applications

The revival of cyclodextrins as active pharmaceutical ingredients

Discovered in 1891, cyclodextrins, derived from starchy food, have found many applications in the cosmetic, agriculture, food and pharmaceutical industries

Continue reading

April 4, 2025 Drug delivery / Pharma applications

Modified release and permeation of umifenovir with SBE-β-CD and polymer: Impact of biorelevant gastrointestinal fluids

In this study, solubility, dissolution and permeation processes of poor soluble antiviral anti-SARS-CoV-2 umifenovir (UMF) were improved with sulfobutylether-β-cyclodextrin (SBE-β-CD)

Continue reading

August 5, 2024 Drug delivery / Pharma applications

Pulmonary Vasodilating Effects of a New Drug Formulation Containing a NO Donor Metabolite (SIN-1A) stabilized by CD

Sin1A is an unstable NO releasing metabolite of Molsidomine. Molsidomine is a prodrug that undergoes first-pass metabolism in the liver,

Continue reading

July 17, 2024 Drug delivery / Pharma applications

Veklury is the first approved antiviral agent now for extended pediatric use and for those patients who are suffering in all stages of renal disease

Veklury, a SARS-CoV-2 nucleotide analog RNA polymerase inhibitor, was approved by FDA for the treatment COVID-19 in adults and pediatric

Continue reading

July 16, 2024 Drug delivery / Pharma applications

Dual function of sulfobutylether-betadex in antiviral Veklury®: a remdesivir solubilizer and an effector

A recent publication written by a team of University of Debrecen reported that the excipient, sulfobutylether-betadex (SBECD), in Veklury® (remdesivir

Continue reading

March 6, 2024 CD as API / Pharma applications

Hydroxypropyl-Beta Cyclodextrin Barrier Prevents Respiratory Viral Infections

The emergence and mutation of pathogenic viruses have been occurring at an unprecedented rate in recent decades. The coronavirus disease

Continue reading

May 11, 2023 Drug delivery / Pharma applications

Complexes of lycorine and its hydrochloride

Lycorine is a toxic crystalline alkaloid found in various Amaryllidaceae species, such as the cultivated bush lily (Clivia miniata), surprise

Continue reading

Posts pagination

1 2 3 … 14 Next Posts»

Recent Posts

  • Book chapter: Functionalized cyclodextrins in drug delivery
  • β-Cyclodextrin-Complexed 1,8-Cineole Attenuates Motor Deficits and Preserves Tyrosine Hydroxylase Immunoreactivity in a Reserpine-Induced Mouse Model of Parkinsonism
  • Disruption of endosomal transport in cyclodextrin-mediated cytotoxicity
  • New Hungarian Medicine on the Horizon?
  • Rafael Holdings Announced Submission of New Drug Application to FDA for Trappsol®Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (361)
  • CD derivatives (442)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (831)
  • E-ducation (64)
  • Environmental (144)
  • Events (242)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (428)
  • Other industrial use (114)
  • Pharma applications (1,240)
  • Supramolecular systems (45)
  • Uncategorized (174)

Top Posts

  • New Hungarian Medicine on the Horizon?
  • Chapter 3: Professor Casu and Cyclodextrins
  • Novel medicament comprising fosaprepitant/SBECD has been approved.
  • Gilead Announces Approval of Veklury® (remdesivir) in Japan for Patients With Severe COVID-19
  • New book on beta-cyclodextrin and its derivatives
  • A Novel In Situ Gelling System of Quercetin/Sulfobutyl-Ether-β-Cyclodextrin Complex-Loaded Chitosan Nanoparticles for the Treatment of Vulvovaginitis
  • Wound dressing based on PVP/PVA nanofibers containing β-cyclodextrin/curcumin complex
  • Oculis aces the Phase 2 clinical trial for OCS-01 treating DME
  • Book chapter: Functionalized cyclodextrins in drug delivery
  • Nature.com: HPBCD treatment improves learning and executive function in Alzheimer model mice

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,470 other subscribers
Loading Comments...